Ladenburg Thalmann Maintains Buy on Crescent Capital BDC, Lowers Price Target to $14

Crescent Capital BDC, Inc.

Crescent Capital BDC, Inc.

CCAP

0.00

Ladenburg Thalmann analyst Christopher Nolan maintains Crescent Capital BDC (NASDAQ: CCAP) with a Buy and lowers the price target from $15 to $14.